Holen Sie sich die Stockscreener-App
3.0627
1.25%
-0.0373
Schlusskurs vom Vortag:
$3.10
Offen:
$3.105
24-Stunden-Volumen:
184.89K
Relative Volume:
0.29
Marktkapitalisierung:
$242.52M
Einnahmen:
$130.42M
Nettoeinkommen (Verlust:
$18.64M
KGV:
14.04
EPS:
0.2182
Netto-Cashflow:
$4.05M
1W Leistung:
-3.44%
1M Leistung:
-1.89%
6M Leistung:
-40.10%
1J Leistung:
-67.37%
1-Tages-Spanne:
$3.03
$3.105
1-Wochen-Bereich:
$3.03
$3.235
52-Wochen-Spanne:
$2.87
$10.52
Niagen Bioscience Inc Stock (NAGE) Company Profile
Firmenname
Niagen Bioscience Inc
Sektor
Branche
Telefon
310-388-6706
Adresse
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
3.065 | 245.29M | 130.42M | 18.64M | 4.05M | 0.2182 |
VRTX
Vertex Pharmaceuticals Inc
|
521.27 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.01 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,004.37 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.42 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.19 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-08-16 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-02-14 | Eingeleitet | B. Riley FBR | Buy |
| 2017-11-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-01-03 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - Kalkine
Niagen Bioscience to Present at Longevity Investors Conference - Business Wire
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
NAGE Price History for Niagen Bioscience Stock - Barchart.com
Niagen Bioscience at Midwest IDEAS: cash-rich growth and drug bets - Investing.com India
Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Yahoo Finance
Niagen (NAGE) Results at a Glance: Profit Per Share Falls Below Its Benchmark in Latest Trading; Market Response - vinanet.vn
Niagen Bioscience stock gains GNC, Sam’s Club distribution, Canaccord reiterates buy - Investing.com
Niagen Bioscience Leads The Way With 2 Promising Penny Stocks - Sahm
Supplement Retail Expansions - Trend Hunter
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores - Investing.com
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores By Investing.com - Investing.com India
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - New Castle News
Tieton Capital Management LLC Purchases New Position in Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen (NAGE) Results at a Glance: EPS Does Not Reach the Reported Estimate for the Current Session; Price Reaction: The Stock Gains 4.71%Earnings Stability Report - vinanet.vn
Niagen (NAGE): Closes 0.33% Higher at $3.05 on the Day; Range and Risk: the Supplied Trading Band Runs From $2.90 to $3.20 on the DayAndrews Pitchfork - vinanet.vn
Niagen Bioscience (NAGE) Eases to $3.02 as Support Level Comes into FocusLong Term Entry Picks - Vinanet
Niagen Bioscience (NAGE) Holds Above $2.9 Support as Shares Drift LowerArms Index - vinanet.vn
Niagen Bioscience to Present at Midwest IDEAS Investor Conference - Bitget
Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com India
Niagen Bioscience at canaccord growth conference: cash, science and growth - Investing.com
Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative? - Yahoo Finance
HC Wainwright Forecasts Lower Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 297% Upside Potential Awaits Investor Attention - DirectorsTalk Interviews
Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof - simplywall.st
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com India
HC Wainwright Predicts Weaker Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence - Yahoo Finance
NAGE Stock Price and Chart — NASDAQ:NAGE - TradingView
Sei Investments Co. Increases Holdings in Niagen Bioscience, Inc. $NAGE - marketbeat.com
Niagen Bioscience, Inc. $NAGE Holdings Boosted by Renaissance Technologies LLC - MarketBeat
Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value - Yahoo Finance
Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins - simplywall.st
Q2 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Niagen Bioscience Inc (NAGE) (Q2 2026) Earnings Call Highlights: - GuruFocus
Niagen Bioscience, Inc. Stock 12‑Month Price Target Cut to $12.08, Implies 248% Upside - TradingView
Earnings call transcript: Niagen Bioscience posts q2 2026 growth, lifts spending - Investing.com Canada
Niagen Bioscience (NASDAQ:NAGE) Announces Quarterly Earnings Results, Meets Expectations - MarketBeat
Is Niagen Bioscience Inc (NAGE) Undervalued After Q2 Earnings Mi - GuruFocus
Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates - Yahoo Finance
Niagen Bioscience, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:NAGE) 2026-08-04 - Seeking Alpha
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Niagen Bioscience: Q2 Earnings Snapshot - Barchart.com
Niagen Bioscience, Inc. (NAGE) Q2 FY2026 earnings call transcript - Yahoo Finance
Niagen Bioscience 2026: Revenue $29.79M, EPS $0.01— 10-Q Summary - TradingView
Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - 富途牛牛
[10-Q] Niagen Bioscience, Inc. Quarterly Earnings Report - Stock Titan
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
Niagen Bioscience (NAGE) Earnings Date and Reports 2026 - MarketBeat
Finanzdaten der Niagen Bioscience Inc-Aktie (NAGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Niagen Bioscience Inc-Aktie (NAGE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pamir Ozan | Chief Financial Officer |
Nov 14 '25 |
Buy |
6.81 |
4,465 |
30,406 |
7,372 |
| Pamir Ozan | Chief Financial Officer |
Nov 14 '25 |
Buy |
6.85 |
2,220 |
15,210 |
2,220 |
0.69%
3.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):